PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy

Activity

Progress
1
Course Completed
Activity Information

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: December 14, 2021

Expiration: December 13, 2022

Dirk Arnold
Dirk Arnold, MD, PhD
Michel Ducreux
Michel Ducreux, MD, PhD